Sodiumtaurohyodeoxycholatehydrate , 97% , 38411-85-7

CAS NO.：38411-85-7

Empirical Formula: C26H46NNaO6S

Molecular Weight: 523.7

MDL number: MFCD00271496

PRODUCT Properties

• storage temp.: Store at -20°C
• solubility: DMF: 30 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 20 mg/ml,Ethanol: 20 mg/ml
• form: A crystalline solid
• color: White to off-white
• InChIKey: VNQXUJQHLHHTRC-WMWRQJSFSA-M
• SMILES: [Na+].[S](=O)(=O)([O-])CCNC(=O)CC[C@H]([C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@H]([C@H](C3)O)C[C@@H](CC4)O)C)CC2)CC1)C)C

Description and Uses

Taurohyodeoxycholic acid (THDCA) is a taurine-conjugated form of the secondary bile acid hyodeoxycholic acid . THDCA decreases the size and weight of human gallstones in vitro. It increases bile flow, biliary cholesterol secretion, and biliary lipid secretion in rats. Co-administration of THDCA with taurochenodeoxycholic acid (TCDCA; ) prevents TCDCA-induced hepatotoxicity, increasing bile flow as well as biliary acid and phospholipid secretion in rats. THDCA also reduces myeloperoxidase activity, expression of TNF-α and IL-6, and colonic damage in a mouse model of TNBS-induced ulcerative colitis.

Sodium taurohyodeoxycholate hydrate has been used in a study to assess dose-response data for cytotoxicity, regenerative cell proliferation and secondary oxidative DNA damage in rat livers treated with furan. It has also been used in a study to investigate the use of an immobilized artificial membrane HPLC column to predict bile salt-membrane interactions.

Safety

• WGK Germany: 3
• Storage Class: 11 - Combustible Solids